Connecticut SB 162: AN ACT ESTABLISHING TAX INCENTIVES TO SUPPORT PRESCRIPTION DRUG COMPOUNDING.

Status: REF. TO JOINT COMM. ON Finance, Revenue and Bonding (as of 2024-02-21)

State: Connecticut · Session: 2024 · Bill: SB 162

Subjects: Drugs, Pharmaceutical manufacturing companies, Pharmacies, Tax incentives

Sponsors: Saud Anwar

View Connecticut SB 162 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.